A next-generation oral antifungal capsule powered by Supra Bioavailable Technology, ITJET-SB 130 delivers enhanced tissue penetration, longer half-life and clinically proven broad-spectrum protection against chronic fungal infections.
₹289.69
Supra Bioavailable Technology is an advanced drug delivery system designed to improve the absorption and tissue penetration of Itraconazole. In ITJET-SB 130, it helps deliver consistent therapeutic levels, supports sustained antifungal action, and enhances treatment effectiveness against chronic, superficial, and systemic fungal infections.
ITJET-SB 130 antifungal medication treats fungal infections by inhibiting the growth of disease-causing fungi and preventing them from spreading further. Its advanced Supra Bioavailable Technology enhances absorption and deep tissue penetration, delivering sustained, broad-spectrum antifungal action for effective management of chronic, superficial, and systemic fungal infections.
Unlike conventional Itraconazole capsules, ITJET-SB 130 is formulated with advanced Supra Bioavailable Technology, enabling superior absorption, deeper tissue penetration, and more consistent therapeutic levels. This helps deliver sustained antifungal action, improved patient tolerability, and effective treatment of chronic, stubborn, and systemic fungal infections.
Yes, ITJET-SB 130 is specifically designed for the effective management of chronic and stubborn fungal infections. Its advanced Supra Bioavailable Technology delivers enhanced tissue penetration and sustained antifungal action, helping target infections more effectively while supporting long-lasting clinical outcomes under dermatologist supervision.
Yes, ITJET-SB 130 is clinically indicated for the treatment of certain systemic fungal infections under medical supervision. Its advanced Supra Bioavailable Technology enhances drug absorption and tissue penetration, helping deliver effective antifungal therapy for both systemic and difficult-to-treat fungal infections.
